TrianglePositron Emission Tomography (NCT04175431)
Positron Emission Tomography trial for Prostate Adenocarcinoma (NCT04175431). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adult men with rising PSA after prostate removal and prostate-bed radiation, without conventional-scan metastases. PSA must be below ten ng/mL, with a doubling time between three and eighteen months.
The idea: PSMA or fluciclovine PET scans guide treatment. No disease outside the prostate bed leads to monitoring. Up to three treatable metastatic regions receive surgery or radiation plus abiraterone and prednisone; more regions receive the drugs. Abiraterone suppresses testosterone production.
This phase 2 study plans 100 patients. Evan Yu leads at Fred Hutch/UW, Seattle; two US sites recruit.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.